Treatment targets in patients with type 2 diabetes set by primary care physicians from Central and Eastern Europe

Figures & data

Table 1. Characteristics of respondents in countries included in the study.

Country	Respondents (n)		Age of respondents in years Mean (SD)		Gender (% female)		Years of experience in general practice Mean (SD)		Physicians with specialty in GP/FM (%)		Urbanization (% urban/rural/ mixed area)
	All	Responsible for diabetes care	All	Responsible for diabetes care	All	Responsible for diabetes care	All	Responsible for diabetes care	All	Responsible for diabetes care	All	Responsible for diabetes care
BG	114	104	44.1 (6.9)	44.0 (6.7)	66	66	9.2 (6.0)	9.3 (6.1)	6	4	85/9/6	83/10/7
CZ	214	139	52.0 (8.7)	52.1 (9.0)	71	70	21.9 (9.6)	22.0 (9.8)	98	98	57/18/24	55/18/27
EE	51	50	48.3 (8.2)	48.1 (8,2)	92	92	17.9 (9.0)	18.2 (8.9)	96	98	51/29/20	52/28/20
HU	144	138	53.5 (10.3)	53.4 (10.4)	41	40	21.8 (11.4)	22.0 (11.5)	87	87	56/24/20	57/24/19
LT	31	31	45.1 (9.6)	45.1 (9.6)	68	68	9.0 (4.9)	9.0 (4.9)	83	83	65/23/13	65/23/13
LV	77	75	49.3 (8.1)	49.4 (8.2)	91	92	19.1 (9.3)	19.3 (9.3)	99	99	77/16/8	76/16/8
PL	100	96	46.4 (6.6)	46.5 (6.4)	62	60	16.6 (7.3)	16.5 (7.3)	96	97	47/29/23	46/31/23
SK	57	22	51.8 (8.1)	51.0 (10.3)	77	67	22.6 (8.4)	22.4 (9.8)	100	100	54/20/27	41/36/23
SL	79	58	46.2 (7.7)	46.1 (7.8)	66	66	18.4 (9.1)	18.3 (9.1)	77	78	33/30/37	26/29/45
Total	867	713	49.3 (9.0)	49.0 (9.10	67	66	18.5 (10.0)	18.2 (10.2)	82	80	59/21/20	58/22/20

GP/FM, general practice/family medicine.

Table 2. Percentage of primary care physicians responsible for diabetes care reporting acceptance of specific HbA1c and FPG treatment targets in patients with type 2 diabetes mellitus.

Respondents’ country (n)	HbA1c (%)			FPG (mmol/ l)
	< 6.1	< 6.5^a	< 7.0	< 6.0^a	< 7.0	< 7.8
BG (104)	35	53	12	59	30	11
CZ (139)	72	25	4	59	38	4
EE (50)	22	46	32	64	34	2
HU (138)	39	46	16	66	32	2
LT (31)	30	17	53	68	26	6
LV (75)	33	58	10	54	42	4
PL (96)	29	59	11	79	18	3
SK (22)	47	47	5	59	36	5
SL (58)	21	41	38	45	50	5

HbA1c, glycated haemoglobin; FPG, fasting plasma glucose.

^aThe level recommended by European guidelines (3) in the period of the survey.

Table 3. Percentage of primary care physicians reporting acceptance of specific BP, TC and LDL-C treatment targets in patients with type 2 diabetes mellitus.

Respondents’ country (n)	BP (mmHg)				TC (mmol/l)					LDL-C (mmol/l)
	< 120/80	< 130/80^a	< 140/90	< 160/95	< 4.5^a	< 5.0	< 5.2	< 6.5	< 8.0	< 2.5^a	< 3.0	< 4.0	< 6.0
BG (114)	45	39	17	0	26	26	32	14	2	48	34	10	8
CZ (214)	58	38	3	0	53	23	17	7	0	68	25	6	0
EE (51)	33	61	6	0	31	41	20	8	0	61	37	2	0
HU (144)	48	50	2	0	69	13	15	3	0	79	18	3	0
LT (31)	45	48	6	0	13	26	35	26	0	55	13	23	10
LV (77)	53	42	5	0	58	31	6	3	1	72	26	0	1
PL (100)	33	64	2	1	57	26	17	0	0	73	18	9	0
SK (57)	67	32	2	0	28	37	35	0	0	66	30	2	2
SL (79)	35	64	1	0	79	21	0	0	0	87	10	3	0

BP, blood pressure; TC, total cholesterol; LDL-C, LDL-cholesterol.

^aThe level recommended by European guidelines (3) in the period of the survey.

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary: Fourth joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2007;28:2375–414.

 PubMed Web of Science ®Google Scholar